At PRISYM ID we’re keen to understand how medical device, pharmaceutical and clinical trial companies check the labels they print for quality.
Early this year we undertook a survey and asked people from the industry:
- If they track the errors identified at the point labels are printed
- How much impact has the labeling inspection on the organisation
- How do they inspect their finished label
- And many other specific questions.
The results help to gain a snap shot of how the industry is meeting the label regulatory requirements today.
Read our whitepaper which explains the results: